| Product Code: ETC6738830 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China capecitabine import market in 2024 saw a notable presence of shipments from top exporting countries such as Puerto Rico, Metropolitan France, Germany, Spain, and Italy. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the Compound Annual Growth Rate (CAGR) from 2020 to 2024 was negative at -2.06%. The growth rate from 2023 to 2024 also experienced a significant decline of -26.63%, indicating a challenging market environment for capecitabine imports in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Capecitabine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Capecitabine Market Revenues & Volume, 2021 & 2031F |
3.3 China Capecitabine Market - Industry Life Cycle |
3.4 China Capecitabine Market - Porter's Five Forces |
3.5 China Capecitabine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 China Capecitabine Market Revenues & Volume Share, By Drug Formulation, 2021 & 2031F |
4 China Capecitabine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing awareness about capecitabine as a chemotherapy option |
4.2.3 Advancements in healthcare infrastructure and access to cancer treatment facilities in China |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new drugs in China |
4.3.2 Competition from alternative cancer treatment options |
4.3.3 Price fluctuations in raw materials affecting the cost of capecitabine production |
5 China Capecitabine Market Trends |
6 China Capecitabine Market, By Types |
6.1 China Capecitabine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 China Capecitabine Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 China Capecitabine Market Revenues & Volume, By Colon Cancer, 2021- 2031F |
6.1.4 China Capecitabine Market Revenues & Volume, By Rectal Cancer, 2021- 2031F |
6.1.5 China Capecitabine Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.6 China Capecitabine Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.2 China Capecitabine Market, By Drug Formulation |
6.2.1 Overview and Analysis |
6.2.2 China Capecitabine Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2.3 China Capecitabine Market Revenues & Volume, By Capsules, 2021- 2031F |
7 China Capecitabine Market Import-Export Trade Statistics |
7.1 China Capecitabine Market Export to Major Countries |
7.2 China Capecitabine Market Imports from Major Countries |
8 China Capecitabine Market Key Performance Indicators |
8.1 Number of oncology clinics and hospitals offering capecitabine treatment |
8.2 Patient survival rates and response to capecitabine therapy |
8.3 Research and development investments in improving capecitabine formulations |
9 China Capecitabine Market - Opportunity Assessment |
9.1 China Capecitabine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 China Capecitabine Market Opportunity Assessment, By Drug Formulation, 2021 & 2031F |
10 China Capecitabine Market - Competitive Landscape |
10.1 China Capecitabine Market Revenue Share, By Companies, 2024 |
10.2 China Capecitabine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here